Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6117]

Amber warning for the UK’s access to new medicines post Brexit

Amber warning for the UK’s access to new medicines post Brexit

FDA grants regular approval to dabrafenib and trametinib combination for metastatic non-small cell lung cancer with BRAF V600E mutation

FDA grants regular approval to dabrafenib and trametinib combination for metastatic non-small cell lung cancer...

Existing drugs could benefit patients with bone cancer, genetic study suggests

Existing drugs could benefit patients with bone cancer, genetic study suggests

$Cerdulatinib demonstrates rapid tumour responses in a phase 2 study for relapsed/refractory NHL$

Cerdulatinib demonstrates rapid tumour responses in a phase 2 study for relapsed/refractory NHL

Identifying similarities between next-generation prostate cancer drugs

Identifying similarities between next-generation prostate cancer drugs

HPV testing leads to earlier detection and treatment of cervical pre-cancer

HPV testing leads to earlier detection and treatment of cervical pre-cancer

Gilteritinib, a FLT3 inhibitor, shows promise in relapsed leukaemia

Gilteritinib, a FLT3 inhibitor, shows promise in relapsed leukaemia

First-line immunotherapy can improve survival for subset of lung cancer patients

First-line immunotherapy can improve survival for subset of lung cancer patients

New antibody uses 1-2 punch to potentially treat blood cancers

New antibody uses 1-2 punch to potentially treat blood cancers

Extended nivolumab followup shows durable response in relapsed cHL

Extended nivolumab followup shows durable response in relapsed cHL

More from ecancer